Medpace Holdings (MEDP) EV to EBIT (2016 - 2026)

Medpace Holdings (MEDP) has reported EV to EBIT for 11 consecutive years, with 97.25 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, EV to EBIT rose 40.1% year-over-year to 97.25; the trailing twelve-month figure through Jun 2026 stood at 24.47 (up 33.27% YoY), and the FY2025 full-year result was 28.86, up 35.65% from the prior year.
• EV to EBIT improved to 97.25 in Q2 2026 per MEDP's latest filing, from 92.3 in the prior quarter.
• Across five years, EV to EBIT topped out at 116.57 in Q2 2024 and bottomed at 62.4 in Q3 2022.
• Historically, EV to EBIT has averaged 88.41 across 5 years, with a median of 86.47 in 2023.
• The sharpest annual moves came in 2022 and 2024: EV to EBIT tumbled 47.66% in 2022, then jumped 75.69% in 2024.
• Over 5 years, EV to EBIT stood at 86.04 in 2022, then climbed by 22.21% to 105.14 in 2023, then declined by 27.88% to 75.83 in 2024, then jumped by 32.83% to 100.72 in 2025, then retreated by 3.45% to 97.25 in 2026.
• According to Business Quant data, EV to EBIT over the past three periods registered 97.25, 92.3, and 100.72 for Q2 2026, Q1 2026, and Q4 2025 respectively.